Explore more publications!

Press Releases

VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
Global Health Leaders to Convene in London for Inaugural International Case Management Conference
Dental Laboratories Market Set to Reach USD 13.09 Billion by 2030 | MarketsandMarkets™
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
PsyMetRiC – a new tool to predict physical health risks in young people with psychosis
Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia
Herantis Pharma releases 2H and FY 2025 report today
Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN 
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
MEMS Packaging Substrates Market Projected to Reach $3.23 Billion by 2030
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Joe Bonamassa announces The Spirit of Rory Live from Cork, honoring Rory Gallagher’s legacy in a powerful performance
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…
“Fined $750,000 for discriminatory speech”- BC’s Barry Neufeld explains his case with News Forum analyst Rav Arora in an exclusive interview
Researchers Break Decades-old Bottleneck in Chemotherapy Drug Manufacturing

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions